Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.
From no evidence of disease activity in MS to studies of a new treatment for periodic paralysis, AAN 2016 featured many exciting clinical trials.
In addition to Guillain-Barré syndrome, a small study from Brazil discussed Zika virus and a possible tie to another autoimmune disorder at AAN 2016.
Two authors of the updated AAN guidelines for treatment with botulinum neurotoxin discussed their findings and potential avenues of further research.
How do you respond when a patient with epilepsy asks about the safety of pregnancy? The WEPOD study investigated pregnancy outcomes and deliveries.
Can use of an online platform improve patient self-management in a group of Veterans with epilepsy?
Does traumatic brain injury (TBI) inevitably lead to psychiatric disorders? Research presented at AAN 2016 aimed to quantify the risk of psychiatric illness after TBI.
Researchers studied the prevalence and incidence of epilepsy in the elderly and confirmed three risk factors in this patient population.
Interactive case study discussions highlighted the issue that treating multiple sclerosis often involves swimming murky waters.
To improve the quality of care for patients with epilepsy, AAN updated a set of measures and guidelines in 2014, but does a gap still exist?